These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8122835)

  • 1. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia.
    Van Pelt F; Ludlow CL; Smith PJ
    Ann Otol Rhinol Laryngol; 1994 Mar; 103(3):192-200. PubMed ID: 8122835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰.
    Chen W; Woo P; Murry T
    J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
    Ludlow CL; Naunton RF; Terada S; Anderson BJ
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngeal electromyographic activity in adductor and abductor spasmodic dysphonia.
    Watson BC; Schaefer SD; Freeman FJ; Dembowski J; Kondraske G; Roark R
    J Speech Hear Res; 1991 Jun; 34(3):473-82. PubMed ID: 2072670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of vocal hyperfunction on relative fundamental frequency during voicing offset and onset.
    Stepp CE; Hillman RE; Heaton JT
    J Speech Lang Hear Res; 2010 Oct; 53(5):1220-6. PubMed ID: 20643798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulcus vocalis in spasmodic dysphonia-A retrospective study.
    Nerurkar NK; Agrawal D; Joshi D
    Am J Otolaryngol; 2021; 42(3):102940. PubMed ID: 33545449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal muscle activity during speech breaks in adductor spasmodic dysphonia.
    Nash EA; Ludlow CL
    Laryngoscope; 1996 Apr; 106(4):484-9. PubMed ID: 8614226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
    Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
    J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adductor muscle stimulation on speech in abductor spasmodic dysphonia.
    Bidus KA; Thomas GR; Ludlow CL
    Laryngoscope; 2000 Nov; 110(11):1943-9. PubMed ID: 11081615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
    Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
    Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal adductor movement of the vocal cords in spasmodic dysphonia].
    Shibusawa M
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Apr; 96(4):659-64. PubMed ID: 8509938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
    Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.
    Koufman JA; Rees CJ; Halum SL; Blalock D
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):97-102. PubMed ID: 16514790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
    Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.